A case of massive pericardial effusion associated with hypocalcemic cardiomyopathy

Tetsuro Yokokawa1, Keiji Sakamoto1, Hiroyuki Mizuno1

  • 1Department of Cardiology, Hoshi General Hospital, Koriyama, Japan.

Journal of Cardiology Cases
|December 15, 2018
PubMed

Insights

Hypocalcemia, a rare cause of heart failure, can lead to reduced ejection fraction and pericardial effusion. Prompt calcium replacement therapy can significantly improve cardiac function in these patients.

Area of Science:

  • Cardiology
  • Endocrinology
  • Internal Medicine

Background:

  • Heart failure and pericardial effusion are serious conditions often requiring complex management.
  • Idiopathic hypoparathyroidism is an endocrine disorder characterized by insufficient parathyroid hormone production, leading to low calcium levels.

Observation:

  • A 60-year-old woman presented with dyspnea, numbness, elevated creatine kinase, and ECG abnormalities, indicative of cardiac distress.
  • Investigations revealed reduced left ventricular ejection fraction (LVEF) and massive pericardial effusion, leading to a heart failure diagnosis.
  • Further testing identified hypocalcemia and idiopathic hypoparathyroidism as underlying causes.

Findings:

  • Calcium replacement therapy, alongside diuretics, successfully improved LVEF and reduced pericardial effusion.
  • This case highlights the potential for severe cardiac manifestations, including heart failure and pericardial effusion, secondary to hypocalcemia.

Implications:

  • Hypocalcemia should be considered in the differential diagnosis of heart failure with reduced ejection fraction and massive pericardial effusion.
  • Numbness, elevated creatine kinase, T wave inversion, and prolonged QT interval can serve as supportive diagnostic indicators for hypocalcemia-induced heart failure.

Related Concept Videos

Behavior of Gas Molecules: Molecular Diffusion, Mean Free Path, and Effusion03:48

Behavior of Gas Molecules: Molecular Diffusion, Mean Free Path, and Effusion

Although gaseous molecules travel at tremendous speeds (hundreds of meters per second), they collide with other gaseous molecules and travel in many different directions before reaching the desired target. At room temperature, a gaseous molecule will experience billions of collisions per second. The mean free path is the average distance a molecule travels between collisions. The mean free path increases with decreasing pressure; in general, the mean free path for a gaseous molecule will be...
31.3K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
566
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
488
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
532
Pleural Effusion I: Introduction01:25

Pleural Effusion I: Introduction

Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
4.3K
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
757